한글목차

경구 백신 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 39억 5,000만 달러에서 2026년에는 43억 5,000만 달러에 이르고, CAGR 10.0%로 성장할 전망입니다. 지난 수년간의 성장에는 백신으로 예방 가능한 질병의 확산, 예방접종의 이점에 대한 인식 증가, 정부의 예방접종 정책, 경구용 소아마비 및 콜레라 백신 개발, 병원 및 클리닉의 예방접종 프로그램 확대 등이 주요 요인으로 꼽힙니다.

경구 백신 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 62억 9,000만 달러에 이르고, CAGR은 9.7%를 나타낼 전망입니다. 예측 기간 동안의 성장에는 새로운 경구용 백신(DNA, RNA, VLP) 출시, 세계 예방접종 프로그램 확대, 디지털 헬스 및 모니터링 도구의 통합, 백신 연구개발에 대한 투자 증가, 성인 및 여행자 백신에 대한 집중도 강화 등이 주요 요인으로 작용할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 소아 예방접종에서 경구용 백신 채택 확대, 헬스케어 및 집단 예방접종 프로그램에 대한 관심 증가, 약독성 생백신 및 서브유닛 경구용 백신 개발, 정부 지원 예방접종 캠페인 확대, 백신 유통을 위한 콜드체인 및 물류 혁신 통합 등이 있습니다. 및 물류 혁신의 통합 등을 들 수 있습니다.

감염병 확산이 심각해짐에 따라 향후 몇 년 동안 경구용 백신 시장은 확대될 것으로 예측됩니다. 감염은 세균, 바이러스, 곰팡이, 기생충 등 병원성 미생물에 의해 발생하며, 사람 간 또는 환경을 통해 전파됩니다. 이러한 급격한 증가는 국경을 넘어 사람과 병원체가 빠르게 이동하는 세계 이동성 증가와 관련이 있으며, 전 세계 감염 확산에 기여하고 있습니다. 경구용 백신은 많은 병원체의 주요 침입 경로인 장 점막 면역을 활성화시켜 강력한 국소 방어를 실현함으로써 감염병 예방에 탁월합니다. 예를 들어, 2025년 5월 영국 보건안전청이 발표한 데이터에 따르면, 영국 내 결핵(TB) 환자 수는 2023년 전년 대비 11.0% 증가했다고 합니다. 이러한 감염성 질환 증가 추세는 경구용 백신 시장의 성장을 견인하고 있습니다.

경구용 백신 시장의 주요 기업들은 면역 활성화를 강화하고 투여를 간소화하는 2세대 경구용 정제 백신과 같은 최첨단 옵션을 추진하고 있습니다. 2세대 정제형 경구용 백신은 항체 생성을 촉진하고, 적용 범위를 확대하며, 주사바늘이나 냉장 보관이 필요 없는 광범위한 백신 접종을 가능하게 합니다. 예를 들어, 2025년 3월 미국 생명공학 기업 Vaxart는 개량형 경구용 노로바이러스 정제 백신의 임상 1상 시험을 시작했습니다. 이번 시험은 개선된 버전의 면역 효과와 안전성을 평가하여, 전 세계적으로 지속 가능한 실용적인 노로바이러스 예방책에 대한 수요에 대응하기 위한 것입니다. 이 회사의 정제 설계는 주사의 장벽을 없애고, 특히 전염병이 유행할 때 신속하고 광범위하게 배포할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

An oral vaccine is a type of immunization administered through the mouth-typically in liquid, tablet, or capsule form-to stimulate an immune response against specific pathogens. These vaccines introduce antigens via the gastrointestinal tract, enabling the immune system to recognize and respond effectively to the targeted disease.

The main types of oral vaccines include live attenuated vaccines, inactivated vaccines, subunit vaccines, and others. Live attenuated vaccines contain weakened forms of pathogens that trigger a strong immune response without causing the disease. Oral vaccines are applied for the prevention of diseases such as polio, tuberculosis, rabies, influenza, cholera, and more. Key end users include hospitals, clinics, government health organizations, and other healthcare providers.

Tariffs have impacted the oral vaccine market by increasing costs of imported vaccine antigens, excipients, and packaging materials, affecting vaccine manufacturing and distribution. Segments like live attenuated and inactivated vaccines are most affected, particularly in regions such as North America, Europe, and Asia-Pacific. This has led to higher treatment costs and potential delays in immunization programs. On the positive side, tariffs have encouraged local vaccine production, investment in domestic manufacturing infrastructure, and innovation in vaccine delivery technologies.

The oral vaccine market research report is one of a series of new reports from The Business Research Company that provides oral vaccine market statistics, including oral vaccine industry global market size, regional shares, competitors with a oral vaccine market share, detailed oral vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the oral vaccine industry. This oral vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral vaccine market size has grown strongly in recent years. It will grow from $3.95 billion in 2025 to $4.35 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to prevalence of vaccine-preventable diseases, rising awareness of immunization benefits, government vaccination initiatives, development of oral polio and cholera vaccines, growth of hospital and clinic vaccination programs.

The oral vaccine market size is expected to see strong growth in the next few years. It will grow to $6.29 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to launch of novel oral vaccines (dna, rna, vlp), expansion of global immunization programs, integration of digital health and monitoring tools, rising investment in vaccine research and development, increased focus on adult and travel vaccinations. Major trends in the forecast period include rising adoption of oral vaccines for pediatric immunization, increasing focus on preventive healthcare and mass vaccination programs, development of live attenuated and subunit oral vaccines, expansion of government-funded immunization campaigns, integration of cold chain and logistics innovations for vaccine distribution.

The escalating prevalence of infectious diseases is set to boost the oral vaccine market in the coming years. Infectious diseases stem from pathogenic microbes like bacteria, viruses, fungi, or parasites, spreading person-to-person or via surroundings. Their surge links to intensified global mobility, swiftly ferrying people and germs across frontiers and amplifying worldwide outbreaks. Oral vaccines excel against infectious diseases by triggering gut mucosal immunity-a key invasion route for many pathogens-delivering robust on-site defense. For example, in May 2025, the UK Health Security Agency reported an 11.0% rise in England's tuberculosis (TB) cases in 2023 versus 2022. Thus, the climbing tide of infectious diseases is fueling the oral vaccine market.

Leading firms in the oral vaccine market are advancing cutting-edge options like second-generation oral pill vaccines to amplify immune activation and simplify delivery. A second-generation pill-based oral vaccine boosts antibody production, extends coverage, and facilitates widespread vaccination sans needles or refrigeration. For instance, in March 2025, Vaxart Inc., a US biotechnology company, kicked off a Phase 1 trial for its upgraded oral norovirus vaccine in pill form. The study assesses enhanced immunity and safety of the refined versions, targeting the persistent worldwide demand for practical norovirus protection. Its pill design eliminates injection hurdles and enables swift, broad deployment, especially amid epidemics.

In March 2024, the International Vaccine Institute (IVI), a South Korea-based non-profit advancing global vaccines, allied with Biological E. Limited to produce a streamlined oral cholera vaccine (OCV-S) for India and beyond. This collaboration lets IVI share expertise to guide clinical trials and approvals, yielding affordable oral cholera shots. Tech transfer wraps up by 2025 to counter surging global cholera threats. Biological E. Limited is an India-based oral vaccine producer.

Major companies operating in the oral vaccine market are Panacea Biotec Ltd., Zydus Lifesciences, Serum Institute of India Pvt. Ltd., Bharat Biotech Ltd., Haffkine Biopharmaceutical Co. Ltd., Medigen Vaccine Biologics Corp., BlueWillow Biologics Inc.

North America was the largest region in the oral vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral vaccine market consists of sales of oral booster doses, oral vaccine delivery systems, vaccine stabilizers, and mucosal immunology research tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Vaccine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses oral vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oral vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Vaccine Type: Live Attenuated Vaccines; Inactivated Vaccines; Subunit Vaccines; Other Vaccine Types
• 2) By Application: Polio; Cholera; Other Applications
• 3) By End-User: Hospital ; Clinics; Government Organization; Other End-Users
• Subsegments:
• 1) By Live Attenuated Vaccines: Oral Polio Vaccine (OPV); Rotavirus Vaccine; Oral Typhoid Vaccine; Oral Cholera Vaccine
• 2) By Inactivated Vaccines: Inactivated Polio Vaccine (IPV); Inactivated Cholera Vaccine; Inactivated Hepatitis A Vaccine
• 3) By Subunit Vaccines: Protein Subunit Vaccines; Polysaccharide Vaccines; Conjugate Vaccines
• 4) By Other Vaccine Types: Virus-Like Particle (VLP) Vaccines; Recombinant Vector Vaccines
• Companies Mentioned: Panacea Biotec Ltd.; Zydus Lifesciences; Serum Institute of India Pvt. Ltd.; Bharat Biotech Ltd.; Haffkine Biopharmaceutical Co. Ltd.; Medigen Vaccine Biologics Corp.; BlueWillow Biologics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Oral Vaccine Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Oral Vaccine Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Oral Vaccine Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Oral Vaccine Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Oral Vaccines For Pediatric Immunization
  • 4.2.2 Increasing Focus On Preventive Healthcare And Mass Vaccination Programs
  • 4.2.3 Development Of Live Attenuated And Subunit Oral Vaccines
  • 4.2.4 Expansion Of Government-Funded Immunization Campaigns
  • 4.2.5 Integration Of Cold Chain And Logistics Innovations For Vaccine Distribution

5. Oral Vaccine Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Government Organizations
• 5.4 Community Health Centers
• 5.5 Travel And Immunization Clinics

6. Oral Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Oral Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Oral Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Oral Vaccine Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Oral Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Oral Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Oral Vaccine Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Oral Vaccine Market Segmentation

• 9.1. Global Oral Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Other Vaccine Types
• 9.2. Global Oral Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polio, Cholera, Other Applications
• 9.3. Global Oral Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital, Clinics, Government Organization, Other End-Users
• 9.4. Global Oral Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Polio Vaccine (OPV), Rotavirus Vaccine, Oral Typhoid Vaccine, Oral Cholera Vaccine
• 9.5. Global Oral Vaccine Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inactivated Polio Vaccine (IPV), Inactivated Cholera Vaccine, Inactivated Hepatitis A Vaccine
• 9.6. Global Oral Vaccine Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Protein Subunit Vaccines, Polysaccharide Vaccines, Conjugate Vaccines
• 9.7. Global Oral Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Virus-Like Particle (VLP) Vaccines, Recombinant Vector Vaccines

10. Oral Vaccine Market Regional And Country Analysis

• 10.1. Global Oral Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Oral Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Oral Vaccine Market

• 11.1. Asia-Pacific Oral Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Oral Vaccine Market

• 12.1. China Oral Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Oral Vaccine Market

• 13.1. India Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Oral Vaccine Market

• 14.1. Japan Oral Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Oral Vaccine Market

• 15.1. Australia Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Oral Vaccine Market

• 16.1. Indonesia Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Oral Vaccine Market

• 17.1. South Korea Oral Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Oral Vaccine Market

• 18.1. Taiwan Oral Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Oral Vaccine Market

• 19.1. South East Asia Oral Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Oral Vaccine Market

• 20.1. Western Europe Oral Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Oral Vaccine Market

• 21.1. UK Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Oral Vaccine Market

• 22.1. Germany Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Oral Vaccine Market

• 23.1. France Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Oral Vaccine Market

• 24.1. Italy Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Oral Vaccine Market

• 25.1. Spain Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Oral Vaccine Market

• 26.1. Eastern Europe Oral Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Oral Vaccine Market

• 27.1. Russia Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Oral Vaccine Market

• 28.1. North America Oral Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Oral Vaccine Market

• 29.1. USA Oral Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Oral Vaccine Market

• 30.1. Canada Oral Vaccine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Oral Vaccine Market

• 31.1. South America Oral Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Oral Vaccine Market

• 32.1. Brazil Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Oral Vaccine Market

• 33.1. Middle East Oral Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Oral Vaccine Market

• 34.1. Africa Oral Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Oral Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Oral Vaccine Market Regulatory and Investment Landscape

36. Oral Vaccine Market Competitive Landscape And Company Profiles

• 36.1. Oral Vaccine Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Oral Vaccine Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Oral Vaccine Market Company Profiles
  • 36.3.1. Panacea Biotec Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Zydus Lifesciences Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bharat Biotech Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Haffkine Biopharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Oral Vaccine Market Other Major And Innovative Companies

• Medigen Vaccine Biologics Corp., BlueWillow Biologics Inc.

38. Global Oral Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Oral Vaccine Market

40. Oral Vaccine Market High Potential Countries, Segments and Strategies

• 40.1 Oral Vaccine Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Oral Vaccine Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Oral Vaccine Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer